To: Andrew Vance who wrote (12648 ) 3/9/1998 1:46:00 PM From: Papillon Read Replies (1) | Respond to
Thank you very much for your opinions, AV, I respect them. Among the stocks you've discussed, I'm holding CYMI and IDTI, and keeping an eye on the others. I went back into MRVC this morning, having taken a little profit last week. Smartmoney mag named it one of the "five stocks of tomorrow," or something like that last week. The issue with this coverage has not actually hit the streets yet, I believe, and should be worth a point when it does. I shorted RAYS this morning for 7/16s of a point in two hours. There were too many block size trades at the ask for my liking, so I got out quickly. If you are interested in moving out of your special area a little, take a look at PFE. Have you heard of Viagra? This drug is still a few weeks from final approval, but over the last six months it has driven Pfizer to amazing levels. By all classical valuations, Pfizer is way overpriced and if Viagra were to be disapproved (won't happen) the stock would fall 20pts in one day. When it is approved it will jump 10 pts. Pfizer has paid a dividend for something like 70 straight quarters and has a very good pipeline. It's high right now, but they are about to have a billion dollar drug approved. PFE, on any dips over the next week, is a buy (with some risk, but ain't there always). And here's a little tidbit for Rachel, just to see if she's here -- the deep, deep rumor about Viagra is that although its pending approval is for male erectile dysfunction, it also works for women, because it stimulates blood flow in the pelvic region. Years from approval for women, but there is nothing to stop physicians from prescribing for women.
